It is now becoming largely accepted that the non-coding portion of the genome, rather than its coding counterpart, is likely to account for the greater complexity of higher eukaryotes. Moreover, non-coding RNAs have been demonstrated to participate in regulatory circuitries that are crucial for development and differentiation. Whereas the biogenesis and function of small non-coding RNAs, particularly miRNAs (microRNAs), has been extensively clarified in many eukaryotic systems, very little is known about the long non-coding counterpart of the transcriptome. In the present review, we revise the current knowledge of how small non-coding RNAs and lncRNAs (long non-coding RNAs) impinge on circuitries controlling proper muscle differentiation and homoeostasis and how their biogenesis is regulated. Moreover, we provide new insights into an additional mechanism of post-transcriptional regulation mediated by lncRNAs, which, acting as miRNA 'sponges', have an impact on the distribution of miRNA molecules on their targets with features similar to those described for ceRNAs (competing endogenous RNAs).
The molecular basis of skeletal muscle development
The skeletal muscle system of vertebrates originates through a discrete series of complex morphogenetic events, globally known as myogenesis. During embryogenesis, muscles of the trunk and limbs derive from somites, which are able to respond to certain inductive signals with the activation of a gene expression programme that leads to specification and differentiation of muscle progenitor cells. A second wave of muscle formation occurs in the adult life to allow muscle growth and maintenance and is carried out by a population of adult stem cells called satellite cells.
The transcriptional network leading to muscle differentiation has been deeply dissected by genetic approaches and has been ascribed to a specific class of transcription factors called MRFs (myogenic regulatory factors). MRFs are basic helix-loop-helix domain-containing proteins, whose expression is limited to the muscle lineage and leads to the Key words: Duchenne muscular dystrophy, long non-coding RNA (lncRNA), microRNA (miRNA), muscle differentiation. Abbreviations used: ceRNA, competing endogenous RNA; CMV, cytomegalovirus; DIST, distal; linc-MD1, long non-coding MD1; lncRNA, long non-coding RNA; MEF2, myocyte enhancer factor 2; miRNA, microRNA; MRF, myogenic regulatory factor; Myf5, myogenic factor 5; MyoD, myogenic differentiation 1; MyoG, myogenin; pre, precursor; pri, primary; PROX, proximal; RT, reverse transcription; SRF, serum response factor; UTR, untranslated region. activation of a cascade of events resulting in the formation of mature muscle fibres with their specific morphological and physiological features. Certain MRFs are required for specification of muscle progenitor cells, whereas other factors are active in terminal differentiation of myoblasts into mature fibres. Myf5 (myogenic factor 5) and MyoD (myogenic differentiation 1) are considered the master genes of muscle tissue specification. Knockout studies in mouse have shown that they act together upstream of the MyoG (myogenin)-driven differentiation cascade. Even if their expression is temporally different, with Myf5 appearing earlier, they seem to act in a redundant fashion, since only double knockout mice have been reported to show a complete deficiency in muscle tissue development [1] . This means that the transcriptional network directing muscle differentiation is robust, with different stimuli converging to the activation of a common gene expression programme. Upstream regulators of early MRFs are paired-domain-and homeobox-containing proteins Pax3 and Pax7, with the first being more active in embryogenesis downstream of Six and Eya families of proteins [2] , whereas the second is particularly important in adult myogenesis [3] . MyoG and Mrf4 (also known as Myf6) are the factors required for terminal differentiation of myoblasts, with Mrf4 shown to also play a role in progenitor cell specification together with Myf5 and MyoD [4, 5] . They act in concert with other factors, including MEF2 (myocyte enhancer factor 2) family and SRF (serum response factor), to activate genes responsible for muscle fibre architecture and functionality (e.g. myosin genes, muscle creatine kinase and dystrophin). Muscle-specific genes let myoblasts mature into myocytes, which are able to fuse and form polynucleated, contractile muscle fibres.
miRNA (microRNA) in myogenesis
miRNAs have recently emerged as crucial determinants for cellular lineage decision. By a peculiar repressing activity on the 3 UTR (untranslated region) of target mRNAs, miRNAs have been reported to confer proper timing and robustness or differentiation programmes. The process of muscle differentiation occurring in both embryonic and adult muscle precursors is accompanied by the induction of a specific class of miRNAs, whose expression is driven by MRF-and other myogenic-dependent transcription factors [6, 7] . Muscle-specific miRNAs were indeed shown to act on different levels in the modulation of muscle differentiation and homoeostasis and their expression was found to be altered in several muscular disorders such as myocardial infarction, Duchenne muscular dystrophy and other myopathies [8, 9] .
Among miRNAs specifically expressed in muscles, the most widely studied are members of the miR-1/206 and miR-133 families, which originate from three separate chromosomes [10] . miR-1 and miR-133 have distinct roles in modulating skeletal muscle proliferation and differentiation in cultured myoblasts in vitro; miR-1 promotes myogenesis by targeting, among the others, HDAC4 (histone deacetylase 4), whereas miR-133 controls myoblast proliferation by repressing SRF and MAML1, a co-activator of MEF2C transcription factor [10, 11] . Unlike miR-1, miR-206 expression is restricted to skeletal muscles where it plays a crucial role in the differentiation of activated satellite cells by targeting Pax7 mRNA [9] , and in myoblast differentiation by targeting multiple genes related to a proliferative state [12] [13] [14] .
The genes encoding the two muscle-specific miRNA families are organized into three bicistronic clusters:
The transcription regulation of these loci has been attributed to different myogenic factors (MyoD, MyoG, Mef2 and SRF) with peculiar patterns of binding and spatiotemporal activation of each cluster [6, 7, 11, 15] . In the case of the miR-1/miR-133 loci, two distinct cis-regulatory elements were described upstream of each miRNA coding region [15] . However, long non-coding transcripts, spanning long regions across these loci, were found and defined as miRNA precursors, suggesting that the two miRNAs could originate by processing from a common precursor [10] . Recent findings on the miR-206/miR-133b cluster support the hypothesis that the host lncRNA (long non-coding RNA) may have its own function independent of that of an miRNA precursor (see below) and that a more complex biosynthetic pathway underlies the expression of the two members of the cluster. Several reports show that Drosha cleavage occurs cotranscriptionally [16] and that, as a consequence of processing of the upstream miRNA, Xrn2 exonuclease activity induces transcriptional termination on downstream sequences [17] ; therefore the existence of a common precursor of multiple miRNAs is very unlikely in those cases where distantly spaced species are present. In line with this, cytoplasmic lncRNAs harbouring unprocessed miRNA sequences would most probably represent molecules escaped from Drosha cleavage in the nucleus. These findings raise the relevant question as to how the fate of a pri (primary)-miRNA transcript is controlled for the alternative production of miRNA or lncRNA. As recently demonstrated for let-7 [18] , it would be interesting to analyse whether miRNAs could have a nuclear phase in association with their primary transcript, thus affecting different steps of their biogenesis.
The miR-206/miR-133b locus spans 13 kb in chromosome 1 of the mouse genome (Figure 1 ). Evidence has been found for the existence in this genomic locus of two promoters with different activation timing: first, 5 RACE (rapid amplification of cDNA ends) and promoter fusion experiments indicated the existence of two transcriptional start sites [DIST (distal) and PROX (proximal)], and secondly, ChIP (chromatin immunoprecipitation) experiments for RNA polymerase II and several epigenetic markers indicated a different chromatin structure of the two transcriptional units during differentiation [11] .
Promoter fusions and gene expression analysis revealed that in proliferating myoblasts, the PROX promoter is active and drives the expression of miR-206. No miR-133b is produced under these conditions; this is likely to be due to efficient miR-206 Drosha processing and subsequent downstream transcriptional termination. ChIP experiments indeed indicated that under proliferating conditions, no RNA polymerase II is detected on the miR-133b coding region. Upon differentiation, the DIST promoter also becomes active and synergizes with the PROX one via direct physical interaction: the formation of a DNA loop, a characteristic of actively transcribing genes [19] , between the two promoter regions was finally shown by 3C (chromosome conformation capture) analysis [11] . This interaction reinforces miR-206 expression and activates the expression from the DIST promoter of a linc-MD1 (long non-coding MD1) transcript spanning the entire region. From this RNA both miRNAs can be produced; miR-206 from the second intron and miR-133b from the third exon.
Interestingly linc-MD1 was described to be a miR-133b precursor if cleaved by Drosha in the nucleus, or to have its own function if exported to the cytoplasm as a poly-A + unprocessed species [11] . The balance between the production of the cytoplasmic polyA + linc-MD1 species and miR-133b processing in the nucleus is a relevant question to be addressed in the future in order to understand the underlying regulatory mechanism and to clarify whether it represents a more general phenomenon occurring for many of the lncRNAs described previously as pri-miRNA species.
Long non-coding RNAs
Genome-wide studies performed over the last decade have shown that most of the human and mouse genomes are transcribed into various classes of transcripts including thousands of lncRNAs [20, 21] ; moreover, many of them resulted in polyadenylated species. So far, a large range of functions has been attributed to lncRNAs [22] . It is clear that several lncRNA molecules associate with chromatin structures to regulate transcription [23] , whereas others exert their control at the post-transcriptional level [24] . In the cytoplasm, lncRNAs were described to transactivate STAU1-mediated mRNA decay by duplexing with 3 UTRs via Alu elements [25] or, in the case of pseudogenes, to compete for miRNA binding, thereby modulating the de-repression of miRNA targets [26, 27] . Moreover, lncRNAs have also been shown to play a role in muscle disease: DBE-T (DBEtranscript) non-coding RNA was found to derepress a class of genes involved in FSHD (facioscapulohumeral muscular dystrophy) by recruiting Trithorax group proteins to their genomic locus [28] . Recently, through a detailed analysis of the genomic locus encoding the two muscle-specific miRNAs miR-206 and miR-133b, a long intergenic non-coding RNA named linc-MD1 was discovered [11] .
linc-MD1
linc-MD1 was shown to be expressed during early stages of murine myoblast in vitro differentiation [11] . Figure 1 shows the genomic structure of this transcript alongside the location of miR-206 and miR-133b. As indicated above, this transcript originates from the activation of the DIST promoter on induction of differentiation. Notably, the mature linc-MD1 was shown to accumulate in the cytoplasm as a polyadenylated species. Bioinformatic analysis of linc-MD1 revealed the presence of conserved binding sites for miR-133 and miR-135; moreover, functional studies indicated that it is indeed able to bind them and, in doing so, to [29] . In line with this, RNA interference against linc-MD1 delayed the differentiation process whereas its overexpression improved myogenesis [11] . These results indicated that the sponge activity of linc-MD1 could alleviate the repression of miR-133 and miR-135 on MAML1 and MEF2C, allowing their expression and the progression of differentiation. This circuitry, indicating that both mRNAs and lncRNAs can modulate the expression level of each other by competing for a shared pool of miRNAs [27] , is consistent with the recently proposed theory of ceRNA (competing endogenous RNA). Figure 2 represents such a circuitry: binding-site affinity prediction [11] and copy number quantification (I. Legnini, unpublished work) revealed that the balance of this circuitry is in favour of linc-MD1 since it is more abundant (5-30-fold) and has better miRNA-binding sites than Maml1 and Mef2C mRNAs. When the analysis was extended to human primary myoblasts from Duchenne muscular dystrophy patients, an interesting correlation was found between the pathology and the strong down-regulation of linc-MD1 [11] . Compared with control cells, Duchenne muscular dystrophy myoblasts showed a reduced ability to undergo terminal differentiation, accompanied by a reduced and retarded accumulation of muscle-specific markers such as MyoG and MHC (myosin heavy chain). Low levels of linc-MD1 could not produce any sponge activity; in fact, the unaffected accumulation of miR-135 determined low levels of MEF2C; conversely, the strong down-regulation of miR-133 correlated with the upregulation of MAML1. In Duchenne muscular dystrophy cells, the rescue of linc-MD1 through lentivirus-mediated expression produced the expected sponge effect with recovery of both MAML1 and MEF2C expression towards wild-type levels and the partial rescue of the correct timing of the differentiation programme. Similar results were also obtained during differentiation of satellite cells derived from wild-type and mdx animals [11] . These data reinforced the hypothesis of a consistent contribution of linc-MD1 to the muscle differentiation programme and pointed to the relevance of its down-regulation in the pathogenesis of Duchenne muscular dystrophy.
Human linc-MD1
In consideration of the interesting features of murine linc-MD1, we sought to characterize its human counterpart. The deep characterization of the linc-MD1 genomic locus allowed us to identify a homologous transcript in humans, named linc-hMD1, which is encoded in chromosome 6. By combining deep sequencing data and RT (reverse transcription)-PCR analysis, we found the presence of two alternatively spliced poly-A + RNAs, differing by a 219-bp-long alternative exon and spanning almost 15 kb ( Figure 3A) . Similarly to the murine counterpart, both isoforms contain the intronic pre (precursor)-miR-206 sequences and the exonic pre-miR133b. Therefore, as occurs for the murine counterpart, it can be hypothesized that linc-hMD1 acts alternatively as an miRNA precursor, if Drosha cleaves it in the nucleus, or as a sponge for the encoded miRNA (miR-133b), if exported to the cytoplasm as a poly-A + unprocessed species. In order to check its possible 'sponge' activity for miR-133, we tested whether linc-hMD1 was able to derepress a luciferase construct containing the mouse Maml1 3 UTR. Notably, sequence analysis of Maml1 3 UTR showed that the miR-133-binding site is conserved between mouse and humans ( Figure 3B, upper panel) . In order to prevent the release of miR-133b from the linc-hMD1 expression construct, a Drosha version was produced and cloned under the control of the CMV (cytomegalovirus) promoter (phMD1-Drosha; Figure 3B , lower panel) [11] . The mouse Maml1 3 UTR reporter construct was transfected in C2C12 mouse myoblasts with phMD1-Drosha or control plasmid. Luciferase assays indicated that, in the presence of phMD1-Drosha, luciferase activity of the Maml1 reporter was up-regulated. This effect was not observed when a mutant derivative of the miR-133-binding site in the Maml1 3 UTR reporter was used. These data indicated that linc-hMD1 is able to sponge endogenous miR-133 similarly to the mouse counterpart.
In conclusion, despite the overall low degree of sequence conservation between humans and mouse, linc-MD1 displays similar features acting as a sponge for miR-133, thereby regulating its muscle-specific target MAML1.
Overall, these data establish that lncRNAs, together with miRNAs, impose several layers of post-transcriptional control on gene expression regulation during the process of muscle differentiation. With respect to transcriptional regulation, they help to strengthen the temporal barriers of gene expression and provide robustness to those processes that are triggered and initiated by myogenic factors. Luciferase (Luc) assay was carried out using the Dual-Luciferase Reporter Assay System (Promega). Results are derived from at least two independent experiments and are shown as means±S.E.M. *P < 0.05.
